Dr. Abhijit Desai, Managing Director, Evolve Med Spa, is leading Dermatologist from Mumbai. Dr. Desai finished his graduation and Post Graduation in Dermatology from T.N. Medical and Nair Hospital in Mumbai under the Bombay University. Dr. Abhijit Desai has always perceived keen interest in the field of Cosmetic Dermatology and did undergo training in various fields of Cosmetic Dermatology like Aesthetic Laser, Botox and Fillers at the Prestigious Pacific Health in Singapore. Dr. Abhijit Desai has been in private practice since 1997 and has the credit of starting one of the first Aesthetic Laser centre in Mumbai called SkinSense back in 2002. Dr. Abhijit Desai has been very closely associated with the Pacific Healthcare Singapore since 2000 and represents Pacific Healthcare in India as Director Indian Operations.
Evolve Med Spa is a joint venture of Yash Birla Group and Pacific Healthcare, one of the world’s leading healthcare providers. Evolve’s Expertise encompasses Cosmetic Dermatology, Cosmetic & Plastic Surgery, General & Specialist Dentistry and Maxillo Facial Prosthesis. Evolve has centres in Walkeshwar, Prabhadevi, Thane, Bandra, Vileparle, Borivli, Andheri lokhandwala and outlets in Bangalore and Mangalore. Evolve’s expertise encompasses Cosmetic Dermatology, Plastic Surgery, and Dentistry. Our cutting-edge treatments include: Botox; Skin Tightening; Hair Removal; Laser Procedures; Skin Rejuvenation; Rhinoplasty; Facelifts; Threadlifts; Breast Augmentation and Reduction; Liposuction; Implant Dentistry; Endodontics; Orthodontics; Dental Lasers.
Replying to Anurag More of IIFL, Dr.Abhijit Desai, says "We are raising around Rs651mn via IPO."
Which are the areas Evolve is focusing on? What growth do you foresee?
The Healthcare industry in India is currently focused on offering medical treatments primarily in non elective areas such as cardiac, orthopaedic, gynaec and other surgical areas which are primarily illness driven. At Evolve, we are currently not intending to focus on these illness related areas but will be focusing on non-elective areas on cosmetic medical treatments. This area specifically is not corporatised in India and is congested with several fragmented small players, quite a few not even seriously medically inclined. We expect this business to grow @ 30-35% over next few years.
Brief us about your offerings? What makes you different from other players?
Evolve currently is a chain of medical wellness centers focusing on cosmetic surgery, cosmetic dermatology and dentistry. All these three verticals are managed by a panel of internationally qualified doctors. We offer end to end makeover solutions which are provided using proven medical treatments only at the hands of doctors. We are the only corporate brand offering all the three verticals under one roof and having all our treatments done by doctors. We don’t offer technician driven treatments like other players which gives us a sharp edge over our competition in results and quality of treatment.
Are you looking at entering any new segments?
As of now, we intend to continue our focus on the three verticals that we are in and increase our geographical presence. However, we continuously explore ideas to add new services to improve our offering - the only criteria being we want to retain our medical image.
How much are you raising via the IPO? By when are your stocks will get listed?
We are raising around Rs651mn via IPO. Primarily funds will be used for brand building and promotions, expansion of centres across India, and for working capital requirements. We are likely to get listed before the end of this calendar year.
Which are the regions you plan to open new healthcare centers?
We will be opening our cosmetic centres across all metros like, Mumbai, Delhi, etc and major state capitals across India.